Sign in Membership
Provider Payment & Delivery Reform

Provider Payment & Delivery Reform

Coverage of reforms in provider payment systems and hospital financing models that reshape utilization, access dynamics, and downstream commercial implications.
Dec 04, 2024

NHSA Strengthens Control Over Outpatient Spending

Effectively navigating these regulatory changes will have significant and lasting implications for drug manufacturers, particularly in shaping their pricing strategies, reimbursement models, and distribution channel approaches in China.
Nov 06, 2024

Advances in New Technology Add-On Payments for Innovative Medicine in China’s DRG/DIP Framework

In July, China’s National Healthcare Security Administration introduced the CHS-DRG Grouping Plan (Version 2.0), expanding the number of
Oct 15, 2024

▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

Stay ahead of value-based approval and pricing trends for medical services and discover strategic growth opportunities to support clinical and commercial strategies for innovative medical technologies in China.
Oct 02, 2024

Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers

To take advantage of these opportunities, manufacturers must focus on three key success factors.
Aug 28, 2024

Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China

Understanding and strategically applying these trends is crucial for optimizing pricing strategies and enhancing market adoption of innovative medical technologies in China.
Jul 03, 2024

NHSA Quietly Releases Implementation Guides for Establishing Medical Service Pricing Items

In China, both public and private not-for-profit hospitals are required to adhere to the Medical Service Pricing Catalogs to provide
Apr 24, 2024

China Local Pilots Expedite Access to Innovative Medicine

These local experiments focus on speeding up clinical trials, broadening payment options, and incentivizing hospital listings to accelerate access to innovative drugs and medical devices.
Apr 10, 2024

Former CFDA Head Bi Jingquan: Challenges and Solutions in China's Innovative Medicine Market

Bi Jingquan, previously at the helm of the China Food and Drug Administration and instrumental in regulatory overhauls that transformed
Feb 14, 2024

China's DRG/DIP Reform: Bridging Medical Service Pricing and Supporting Tech Innovation

The DRG/DIP payment reform has curtailed the rapid expansion of China's public hospitals, shifting focus to quality
Nov 22, 2023

China's Medical Service Pricing Reform: Current State and Future Development

In our last newsletter, we delved into the three fundamental issues connected with medical service pricing in China: * Fragmented pricing